Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry

Abstract Background While the availability of biological or targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) has improved outcomes for rheumatoid arthritis (RA) patients, there remains a subset of individuals who fail to achieve low disease activity or remission despite multipl...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ju-Yang Jung, Eunyoung Lee, Ji-Won Kim, Chang-Hee Suh, Kichul Shin, Jinhyun Kim, Hyoun-Ah Kim
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-09-01
Series:	Arthritis Research & Therapy
Assuntos:	Rheumatoid arthritis Difficult-to-treat Biologic therapy DMARDs
Acceso en liña:	https://doi.org/10.1186/s13075-023-03165-w
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!